David J. Arthur, Chief Executive Officer at Salarius Pharmaceuticals, Inc. (SLRX), bought 1,000 shares at $1.01 ($1K) on 2020-08-19, disclosed to the SEC on 2020-08-20.
Open-market purchase of $1k SLRX by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| SLRX | BUY | 2021-08-17 | $4K | — | Filing → |
| SLRX | BUY | 2020-02-12 | $3K | — | Filing → |